Serial Number 79225044
Registration 5671918
739

Registration Progress

Application Filed
Oct 11, 2017
Under Examination
Approved for Publication
Nov 27, 2018
Published for Opposition
Nov 27, 2018
Registered
Feb 12, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-02-12) (Grace Period Filing)
Due: Aug 12, 2025 Grace Period - 9 days
Original deadline was Feb 12, 2025 (overdue)

Trademark Image

Basic Information

Serial Number
79225044
Registration Number
5671918
Filing Date
October 11, 2017
Registration Date
February 12, 2019
Published for Opposition
November 27, 2018
Drawing Code
2

Status Summary

Current Status
Active
Status Code
739
Status Date
Jun 20, 2025
Registration
Registered
Classes
005 042 045

Rights Holder

Ascendis Pharma A/S

65
Address
Tuborg Boulevard 5
Hellerup
DK

Ownership History

Ascendis Pharma A/S

Original Applicant
65
DK-2900 Hellerup DK

Ascendis Pharma A/S

Owner at Publication
65
DK-2900 Hellerup DK

Ascendis Pharma A/S

Original Registrant
65
Hellerup DK

Legal Representation

Attorney
Shannon Marie McKeon

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-02-12)
Due Date
February 12, 2025
Grace Period Ends
August 12, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

42 events
Date Code Type Description Documents
Jun 20, 2025 NA75 E NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Loading...
Jun 20, 2025 C75A O REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Loading...
Jun 2, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 12, 2025 ES75 I TEAS SECTION 71 & 15 RECEIVED Loading...
Mar 10, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 12, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Dec 24, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 28, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jun 21, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jun 4, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jun 4, 2019 FIMP P FINAL DISPOSITION PROCESSED Loading...
May 12, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Feb 12, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 27, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 24, 2018 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Nov 16, 2018 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 7, 2018 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Nov 7, 2018 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Nov 7, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 17, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 28, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 27, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 27, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 17, 2018 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 17, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 17, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 17, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 17, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 16, 2018 ALIE A ASSIGNED TO LIE Loading...
Jul 26, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 24, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 24, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 16, 2018 RFNT P REFUSAL PROCESSED BY IB Loading...
Feb 1, 2018 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 1, 2018 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jan 25, 2018 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jan 24, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 23, 2018 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 19, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 19, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 18, 2018 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for use in enzyme replacement therapy; pharmaceutical and veterinary preparations, namely, vaccines for the treatment of physical and mental illness; pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, growth hormone deficiencies, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncological disorders, ophthalmologic disorders, infectious diseases, enzyme replacement therapy, anti-inflammatory diseases, pain, respiratory system disorders, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wounds healing, the hormonal system disorders, namely, growth hormone deficiencies, diabetes and angiogenesis, the ophthalmological system disorders, namely, angiogenesis, the angiogenic system disorders, the central nervous system disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system disorders, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system diseases, the metabolic system disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system disorders, namely, growth hormone deficiencies, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in in ophthalmology; pharmaceutical preparations for use in the treatment of gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides
Class 042
Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in relation to the aforementioned scientific research, conducting of tests regarding medical applications, namely, conducting clinical trials for others, packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, namely, pharmaceutical products development, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
Class 045
Licensing of industrial property; legal services

Additional Information

Design Mark
The mark consists of a polygon that is divided by a white curved band with the top section being in turquoise and the bottom section in blue.
Color Claim
The color(s) turquoise, grey, white and blue is/are claimed as a feature of the mark.

Classification

International Classes
005 042 045